| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
865,224 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
70 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Simpson Todd E |
Chief Financial Officer |
• – – |
2016-08-22 |
4 |
AS |
$46.59 |
$185,943 |
D/D |
(3,991) |
191,445 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-08-08 |
4 |
AS |
$46.92 |
$550,212 |
D/D |
(11,660) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-08-08 |
4 |
OE |
$4.45 |
$75,129 |
D/D |
11,660 |
563,733 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-07-27 |
4 |
AS |
$45.20 |
$182,718 |
D/D |
(4,042) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-07-27 |
4 |
OE |
$10.20 |
$41,228 |
D/D |
4,042 |
560,157 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-07-06 |
4 |
AS |
$40.10 |
$308,999 |
D/D |
(7,618) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-07-06 |
4 |
OE |
$4.45 |
$33,900 |
D/D |
7,618 |
558,561 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-06-06 |
4 |
AS |
$43.22 |
$962,668 |
D/D |
(22,083) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-06-06 |
4 |
OE |
$4.45 |
$182,381 |
D/D |
22,083 |
563,733 |
|
- |
|
| Drachman Jonathan G |
CMO & EVP, R & D |
• – – |
2016-06-02 |
4 |
OE |
$10.29 |
$51,450 |
D/D |
5,000 |
88,246 |
|
- |
|
| Cline Darren S |
EVP, Commercial |
• – – |
2016-06-02 |
4 |
S |
$42.07 |
$141,617 |
D/D |
(3,366) |
42,747 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-27 |
4 |
AS |
$40.10 |
$432,810 |
D/D |
(10,792) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-27 |
4 |
OE |
$10.29 |
$111,050 |
D/D |
10,792 |
566,907 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-26 |
4 |
AS |
$40.07 |
$45,284 |
D/D |
(1,130) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-26 |
4 |
OE |
$10.29 |
$11,628 |
D/D |
1,130 |
557,245 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-25 |
4 |
AS |
$40.51 |
$1,488,275 |
D/D |
(36,738) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-25 |
4 |
OE |
$10.20 |
$377,335 |
D/D |
36,738 |
585,085 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-24 |
4 |
AS |
$40.00 |
$68,000 |
D/D |
(1,700) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-24 |
4 |
OE |
$10.20 |
$17,340 |
D/D |
1,700 |
557,815 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-23 |
4 |
AS |
$40.12 |
$268,777 |
D/D |
(6,700) |
556,115 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2016-05-23 |
4 |
OE |
$10.20 |
$68,340 |
D/D |
6,700 |
562,815 |
|
- |
|
| Welch Daniel G |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
45,519 |
|
- |
|
| Simonian Nancy A |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
14,400 |
|
- |
|
| Lippman Marc E |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
132,350 |
|
- |
|
| Orwin John A |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
14,400 |
|
- |
|
1805 Records found
|
|
Page 31 of 73 |
|
|
